The use of proton spectroscopic imaging in prostate cancer at clinical field strengths of 1.5 and 3T will be discussed. Moreover, latest developments at 3T, as well as the possibilities of 7T are shown for proton as well as phosphorous spectroscopic imaging, culminating in the ultimate multi-parametric MRI examination...
This abstract and the presentation materials are available to members only; a login is required.